Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
2
Neutral
5
Bullish
7
Bearish
33
Neutral
5
Bullish
8
Bearish
31
Neutral
0
Bullish
1
Bearish
31
Neutral
0
Bullish
1
Bearish
31
Neutral
0
Bullish
1
Bearish
31
Neutral
0
Bullish
1
Industrial Products
Glass - Industrial
955 Cr
Low Risk
20.93
30.74
2.20
2.11
181.25
96.65
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q2 FY27
Investor Presentation
Q3 FY26
Investor Presentation
Q3 FY25
Investor Presentation
Q2 FY25
Borosil Scientific Ltd (BOROSCI) is currently trading at 107.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Borosil Scientific manufactures and markets laboratory glassware, consumables, laboratory equipment, pharmaceutical primary packaging, process systems, and consumer glassware through more than 4,500 SKUs, four Indian manufacturing locations, and a global distribution footprint spanning over 90 countries. The company combines a six-decade laboratory glassware franchise with adjacent growth platforms, including LabQuest equipment, Process Sciences, and Klasspack pharmaceutical packaging. This diversification is strategically important because process systems and equipment carry higher-margin potential than the mature core consumables business. Consolidated H1FY27 revenue increased 9.3% year-on-year to ₹221.7 crore, while EBITDA rose 37.8% to ₹19.8 crore and PAT moved from a loss of ₹1.4 crore to a profit of ₹9.7 crore. Growth was led by pharmaceutical packaging and Process Systems, alongside improved performance at Goel Scientific. Management is committing meaningful capital to capacity and supply-chain integration: ₹60 crore for glassware expansion and up to ₹70 crore for a captive borosilicate 3.3 glass tubing furnace. These projects could improve availability, quality control, utilization, and margins, but also introduce execution and capital-allocation risks. The principal near-term tension is between strong consolidated growth and weaker standalone profitability. Standalone Q2FY27 EBITDA declined 9.7% year-on-year as geopolitical tensions increased input costs, while Consumer Glassware sales declined 10.2%; however, process systems, pharma packaging, exports, and localization provide several avenues for recovery.
Over the past 52 weeks, Borosil Scientific Ltd has traded between a low of ₹96.65 and a high of ₹181.25. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Borosil Scientific Ltd has a market capitalization of approximately 954.89. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Borosil Scientific Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 20.93 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 954.89 Cr, Borosil Scientific Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Borosil Scientific Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Borosil Scientific Ltd is 20.93. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Borosil Scientific has set a medium-term revenue CAGR target of 12% to 14%. Management links the target to exports, expansion of LabQuest and Process Sciences, broader offerings for existing clients and new-customer acquisition.
BSL reported consolidated PAT of Rs 5.3 crore in Q2FY27, up 86.3% from Rs 2.9 crore in Q2FY26. Consolidated profit before tax rose 49.5% to Rs 7.7 crore from Rs 5.1 crore.
BSL proposes Rs 60 crore of capital expenditure for its glassware expansion. The project would increase annual capacity from about 15 lakh units to about 108 lakh units, with commercial production expected in March 2027.
Borosil Scientific’s board is scheduled to consider and approve its Q2 and half-year FY27 unaudited results on October 28, 2026.
